Literature DB >> 15879093

IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells.

Shinsuke Taki1, Shinsuke Nakajima, Eri Ichikawa, Takashi Saito, Shigeaki Hida.   

Abstract

NK cell development is far less understood compared with that of T and B cells despite the critical importance of NK cells in innate immunity. Mice lacking the transcription factor IFN regulatory factor-2 (IRF-2) are known to exhibit NK cell deficiency. However, the role of IRF-2 in NK cell development has remained unclear. In this study we found that NK cell deficiency in the periphery in IRF-2-deficient mice was due to selective loss of mature NK cells, but not to maturation arrest, and NK cells in these mice exhibited very immature surface phenotypes (CD11b(low)Dx5(low)) with highly compromised NK receptor expression. In contrast, IRF-2-deficient NK cells in bone marrow (BM) showed relatively mature phenotypes (CD11b(low)Dx5(high)) with less compromised NK receptor repertoire. Furthermore, BM NK cells in IRF-2-deficient mice were found to proliferate almost normally, but underwent accelerated apoptosis. These observations indicated that NK cell maturation could advance up to a late, but not the final, stage in the BM, whereas these cells were incapable of contributing to the peripheral NK cell pool due to premature death in the absence of IRF-2. In contrast, NK cell numbers and Ly49 expression were much more severely reduced in BM in IL-15-deficient mice than in IRF-2(-/-) mice. The differential peripheral and central NK cell deficiencies in IRF-2(-/-) mice thus revealed a novel late checkpoint for NK cell maturation, distinct from the early IL-15-dependent expansion stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879093     DOI: 10.4049/jimmunol.174.10.6005

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Stromal-cell regulation of natural killer cell differentiation.

Authors:  Claude Roth; Carla Rothlin; Sylvain Riou; David H Raulet; Greg Lemke
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

Review 2.  The IRF family, revisited.

Authors:  A Paun; P M Pitha
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

Review 3.  Extrinsic and intrinsic regulation of early natural killer cell development.

Authors:  Markus D Boos; Kevin Ramirez; Barbara L Kee
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  Transcriptional regulation of murine natural killer cell development, differentiation and maturation.

Authors:  Werner Held; Beena Jeevan-Raj; Mélanie Charmoy
Journal:  Cell Mol Life Sci       Date:  2018-06-29       Impact factor: 9.261

5.  Gene structure and transcription of IRF-2 in the mandarin fish Siniperca chuatsi with the finding of alternative transcripts and microsatellite in the coding region.

Authors:  Baojian Sun; Mingxian Chang; Dali Chen; Pin Nie
Journal:  Immunogenetics       Date:  2006-07-27       Impact factor: 2.846

Review 6.  Transcriptional control of natural killer cell differentiation and function.

Authors:  Alfonso Martín-Fontecha; Graham M Lord; Hugh J M Brady
Journal:  Cell Mol Life Sci       Date:  2011-08-24       Impact factor: 9.261

Review 7.  Transcriptional control of natural killer cell differentiation.

Authors:  Marc Brillantes; Aimee M Beaulieu
Journal:  Immunology       Date:  2018-11-18       Impact factor: 7.397

Review 8.  Tissue-specific effector functions of innate lymphoid cells.

Authors:  Niklas K Björkström; Eliisa Kekäläinen; Jenny Mjösberg
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

Review 9.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

10.  NK cell maturation and function in C57BL/6 mice are altered by caloric restriction.

Authors:  Jonathan F Clinthorne; Eleni Beli; David M Duriancik; Elizabeth M Gardner
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.